Publications

4721 Results

Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-world Experiment

Authors
DD Kim;G Guzauskas;C Bennette;A Basu;D Veenstra;S Ramsey;JJ Carlson
Journal / Conference
PharmacoEconomics Feb;38(2):171-179; 2019 Oct 21. doi: 10.1007/s40273-019-00848-8. [Epub ahead of print]
Year
2020
Research Committee(s)
Breast and Gastrointestinal
PMID
PMID31631254
Study Number(s)
S1513

NSABP B-47 / NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy with or without Trastuzumab in High-risk Invasive Breast Cancer Negative for HER2 by ISH and with IHC 1+ or 2+ (HER2-low)

Authors
L Fehrenbacher;R Cecchini;CE Geyer;P Rastogi;J Costantino;JN Atkins;JP Crown;J Polikoff;J-F Boileau;L Provencher;C Stokoe;TD Moore;A Robidoux;PJ Flynn;VF Borges;KS Albain;SM Swain;S Paik;EP Mamounas;N Wolmark
Journal / Conference
Journal of Clinical Oncology Feb 10; 38 (5), 444-453; Dec 10[Online ahead of print]
Year
2020
Research Committee(s)
Breast
PMID
PMID31821109
PMC
PMC Journal - In Process

Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

Authors
WA Woodward;W Barlow;R Jagsi;TA Buchholz;S Shak;F Baehner;C Yoshizawa;T Whelan;N Davidson;J Ingle;T King;P Ravdin;CK Osborne;D Tripathy;R Livingston;J Gralow;G Hortobagyi;D Hayes;K Albain
Journal / Conference
JAMA Oncology Jan 9 [Online ahead of print]
Year
2020
Research Committee(s)
Breast
PMID
PMID31917424
Study Number(s)
SWOG-8814

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The Neuroendocrine Cohort

Authors
S Patel;M Othus;Y Chae;F Giles;D Hansel;P Singh;A Fontaine;M Shah;A Kasi;T Al Baghdadi;S Vasireddy;E Mayerson;CW Ryan;Melissa Plets;CD Blanke;R Kurzrock
Journal / Conference
Clinical Cancer Research (published online CCR)
Year
2020
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Measures of Body Fatness and Height Across the Adult Lifecourse and Risk of Prostate Cancer Incidence and Mortality in the Pooling Project of Prospective Studies of Diet and Cancer.

Authors
JM Genkinger;K Wu;M Wang;D Albanes;A Black;P van den Brandt;MB Cook;SM Gapstur;GG Giles;E Giovannucci;G Goodman;P Goodman;N Hakansson;T Key;S Mannisto;L Le Marchand;L Liao;R MacInnis;M Neuhouser;E Platz;N Sawada;J Schenk Kisser;VL Stevens;RC Travis;S Tsugane;K Visvanathan;RL Wilkens;A Wolk;SA Smith-Warner
Journal / Conference
Annals of Oncology Jan;31(1):103-114
Year
2020
Research Committee(s)
Cancer Control
PMID
PMID31912782
Study Number(s)
SWOG-9217

Rapid Donor Identification Improves Survival in High Risk First Remission AML Patients

Authors
J Pagel;M Othus;G Garcia-Manero;M Fang;J Radich;D Rizzieri;G Marcucci;S Strickland;M Litzow;ML Savoie;S Spellman;D Confer;J Chell;M Brown;B Medeiros;T Lin;G Uy;B Powell;R Bayer;RA Larson;RM Stone;D Claxton;J Essell;S Luger;S Mohan;A Moseley;H Erba;F Appelbaum
Journal / Conference
Journal of Oncology Practice Jan 27:JOP1900133. doi: 10.1200/JOP.19.00133. [Epub ahead of print]
Year
2020
Research Committee(s)
Leukemia
PMID
PMID32048933
Study Number(s)
S1203

A Meta-Analysis of Genome-Wide Association Studies of Multiple Myeloma among African Americans

Authors
Z Du;N Weinhold;C Song;K Rand;D Van Den Berg;A Hwang;X Sheng;V Hom;S Ailawadhi;P Goodman;E Klein;J Zonder;R Orlowski;D Conti;C Haiman;W Cozen
Journal / Conference
Blood Advances Jan 14;4(1):181-190
Year
2020
Research Committee(s)
Cancer Control and Prevention
PMID
PMID31935283
PMC
PMC6960456
Study Number(s)
S0000, SWOG-9217

Diabetes and Clinical Outcome in Patients with Metastatic Colorectal Cancer: CALGB 80405 (Alliance)

Authors
JC Brown;S Zhang;F-S Ou;A Venook;D Niedzwiecki;H-J Lenz;F Innocenti;BH O'Neil;JE Shaw;B Polite;H Hochster;JN Atkins;RM Goldberg;K Ng;RJ Meyer;CD Blanke;E O'Reilly;CS Fuchs;JA Meyerhardt
Journal / Conference
JNCI Cancer Spectrum Volume 4, Issue 1, February 2020
Year
2020
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Results of a Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery for Patients with High Grade Upper Tract Urothelial Carcinoma

Authors
V Margulis;M Puliigandla;E Trabulsi;E Plimack;E Kessler;S Matin;G Godoy;A Alva;N Hahn;M Carducci;J Hoffman-Censits
Journal / Conference
Journal of Urology Nov 8:101097JU0000000000000644.[Epub ahead of print]
Year
2020
Research Committee(s)
Genitourinary
PMID
PMID31702432
Study Number(s)
CTSU/EA8141

Survival outcomes and risk group validation from SWOG S0925, a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer

Authors
R Wong;M Duong;C Tangen;N Agarwal;H Cheng;N Vogelzang;M Hussain;I Thompson;D Quinn;E Yu
Journal / Conference
Prostate Cancer and Prostatic Disease Feb 13. doi: 10.1038/s41391-020-0210-x. [Epub ahead of print]
Year
2020
Research Committee(s)
Genitourinary
PMID
PMID32055002
Study Number(s)
S0925